Immunic
IMUX
64 hedge funds and large institutions have $44.1M invested in Immunic in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 13 closing their positions.
993% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $114K
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
1.18% less ownership
Funds ownership: 5.67% → 4.49% (-1.2%)
2% less funds holding
Funds holding: 65 → 64 (-1)
14% less capital invested
Capital invested by funds: $51.1M → $44.1M (-$6.99M)
29% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$1.14M |
| 2 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$448K |
| 3 |
LCM
Laurion Capital Management
New York
|
+$247K |
| 4 |
6CM
683 Capital Management
New York
|
+$216K |
| 5 |
Jane Street
New York
|
+$165K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$4.57M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.79M |
| 3 |
Janus Henderson Group
London,
|
-$2.69M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$756K |
| 5 |
Morgan Stanley
New York
|
-$580K |
IMUX Hedge Fund Activity: Q1 2025 in Review
64 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2025, worth a combined $44.1M — down 14% from $51.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IMUX and 12 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 12 added.
The largest buyer was Aberdeen Group, opening a new position worth an estimated $1.14M. The largest seller was RTW Investments, exiting entirely with an estimated $4.57M sold.
- 64 institutional investors held Immunic (IMUX) as of Q1 2025, down from 65 in Q4 2024.
- Funds reported $44.1M of Immunic stock for Q1 2025, down 14% quarter-over-quarter.
- 12 funds opened new Immunic positions in Q1 2025 and 13 closed out, a net change of -1 holder.
- The largest Immunic buyer in Q1 2025 was Aberdeen Group, an estimated $1.14M added.
- The largest Immunic seller in Q1 2025 was RTW Investments, an estimated $4.57M sold.
Based on aggregated 13F filings for Q1 2025.